reference/19360823

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19360823

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	1815
issn	0923-7534
issueIdentifier	12
pageRange	1810-1815
publicationName	Annals of oncology : official journal of the European Society for Medical Oncology
startingPage	1810
bibliographicCitation	Mollee P, Arthur C, Hughes T, Januszewicz H, Grigg A, Bradstock K, Wolf M, Gibson J, Schwarer AP, Spencer A, Browett P, Hawkins T, Seldon M, Herrmann R, Watson A, Seymour JF, Martin N, Shina S, Low C, Wright S, Rodwell R, Coulston J, Morton J, Blacklock H, Taylor D, Taylor KM. Interferon-alpha-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemia. Ann Oncol. 2004 Dec;15(12):1810–5. doi: 10.1093/annonc/mdh468. PMID: 15550587.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_530a158a00abb4e84119288db8c0b3c4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3f5e336a6284432e2be33409bed3c0bb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f50b12b3af7cf419b932da3aa455e48d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_26ee4f7a40d5c137972a9c66a99280d9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e82c6246f74a46e4cec85f60c92e800 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6cf80d1a0ffe1491aee47bada4f3c71f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_742e51734b1baca995b20c89f897f18c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2124dcf3ca970bbaf777c493f2d57aeb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0aae0f3a4cd0c55f0db7cf25e50ccb88 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_54d395b65c898d2c99e96227c56e39ef http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cdb3501b795bff3dbdf913e1832b97a6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_43ef67066c9c41637e256d2d70fecc07 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9891d173d4876f4548bb9def7635b8a0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_72270fba957ce7ab5a365aa6d3bdbbcd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_53ba2a8c824b8bb06b2419f6ed4626e5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_600858904659ea5800ae338f08e9efa8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9fce3af8675004a8457587794b1a29b3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5c71200cf4f92cb8e0b377be95a2fb3a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1cab4725875945a0f990ba5742725a49 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1ebf8a46af3c7ad5485c238d77db1224 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_320d83b4b790835aadc6b14e8de40d75 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_57ded66224534ce7df1beddfa190b84c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_33e5366aadd832bd2ed1caac68acd098 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05c7c825166f7bed47c9715b21d4eed3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_14be29d77df8cd5922ff527e999f6ddf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf5681873100434744ce95e1be734ad9
date	200412
identifier	https://doi.org/10.1093/annonc/mdh468 https://pubmed.ncbi.nlm.nih.gov/15550587
isPartOf	https://portal.issn.org/resource/ISSN/0923-7534 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1846
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Interferon-alpha-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemia
discusses	http://id.nlm.nih.gov/mesh/M0005575 http://id.nlm.nih.gov/mesh/M0169659 http://id.nlm.nih.gov/mesh/M0552528 http://id.nlm.nih.gov/mesh/M0018641 http://id.nlm.nih.gov/mesh/M0025711 http://id.nlm.nih.gov/mesh/M0001643
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D003568Q000031 http://id.nlm.nih.gov/mesh/D015464Q000188 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D000971Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D007279 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D001088Q000008 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D011994 http://id.nlm.nih.gov/mesh/D016898Q000008 http://id.nlm.nih.gov/mesh/D015464Q000473 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D003568Q000008 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D000077190
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9727 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663412 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23671562 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d6a1edc08997e3d7b61d7a07051efb5 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918130 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6253

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129367670 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128157154

Total number of triples: 79.